Both companies will expand their cooperation through the distribution of medical cannabis products in the highly attractive Czech and Swiss markets DUSSELDORF, Germany, BARCELONA, Spain
/PRNewswire/ Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), and Panaxia.
Panaxia sells Israeli cannabis pharmacy to focus on exports
Panaxia Israel is selling its pharmacy, one of Israel s largest for cannabis products, to IMC for NIS 20 million.
Six months have gone by since the pilot scheme for exports of cannabis from Israel began, and although exports have not yet received a final official stamp of approval, the activity which for a long time was a dream and a promise is becoming real. Several Israeli cannabis companies, among them InterCure, Univo, BOL Pharma, and Seach Medical Group have already sent consignments to Europe. Tikun Olam-Cannbit has just signed a large marketing agreement in the UK.